Lonza Group AG
LONN
Rang în acțiuni
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Preț acțiune
$764.04
Capitalizare de piață
$53.36B
Schimbare (1 zi)
0.96%
Schimbare (1 an)
8.59%
Țară
CH
Tranzacționează Lonza Group AG (LONN)
Categorie
Healthcare
Venituri pentru Lonza Group AG (LONN)
Venituri în Oct 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Lonza Group AG, venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Lonza Group AG din 2004 până în 2026
Venituri la sfârșitul fiecărui an
| An | Venituri | Schimbă |
|---|---|---|
| 2025 | $8.23B | 35.66% |
| 2024 | $6.07B | -24.04% |
| 2023 | $7.99B | 18.66% |
| 2022 | $6.73B | 13.45% |
| 2021 | $5.93B | 18.22% |
| 2020 | $5.02B | 15.40% |
| 2019 | $4.35B | -22.81% |
| 2018 | $5.63B | 20.73% |
| 2017 | $4.67B | 14.94% |
| 2016 | $4.06B | 6.70% |
| 2015 | $3.80B | 3.83% |
| 2014 | $3.66B | -8.77% |
| 2013 | $4.02B | -6.34% |
| 2012 | $4.29B | 49.65% |
| 2011 | $2.87B | -0.07% |
| 2010 | $2.87B | 10.16% |
| 2009 | $2.60B | -5.33% |
| 2008 | $2.75B | 8.28% |
| 2007 | $2.54B | 35.49% |
| 2006 | $1.87B | 30.23% |
| 2005 | $1.44B | -25.02% |
| 2004 | $1.92B | 0.00% |
Venituri pentru companii similare sau concurente
| Companie | Venituri | Diferență de venituri | Țara |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $6.02B | - |
NL
|
|
| $10.11B | - |
BE
|
